474. THE EFFECT OF ADOLESCENT PRE-TREATMENT WITH THE SELECTIVE CANNABINOID 1 RECEPTOR AGONIST ON HIPPOCAMPAL THETA SYNCHRONIZATION IN ADULTHOOD

Abstract Background Historically, concern around adolescent marijuana use focused on the development of psychosis, however recent findings indicate that cognitive domains may also be at risk. CB1R was shown to interfere with neuronal network oscillations and to impair sensory gating function. Neuronal oscillations are essential in multiple cognitive functions and their impairment was documented in neurological and psychiatric diseases. The Cannabinoid 1-receptor (CB1R), one of the most abundant G-protein coupled receptors in the nervous system, is found in particularly high levels in the hippocampus (HPC). Increased CB1R density and binding observed in patients with schizophrenia and epidemiological studies suggest that regular cannabis use during adolescence is a risk factor for the disease. Aims & Objectives The aim of this study was to investigate how adolescent pre-treatment with the CB1R selective agonist CP-55940 may lead to abnormal theta synchronization in adulthood. Two of our previous findings served as scientific premise of the project: 1. CP-55940 significantly reduced theta and gamma power in HPC in adult freely behaving and theta in anesthetized rats, the latter reversed by CB1R antagonist AM-251 [1] and 2. it was shown in urethane anaesthetized rats that early adolescence is critical for development of HPC networks generating theta rhythm as HPC theta power rapidly decreased through postnatal days PND32-39 with large interindividual variations but stabilized by late adolescence (PND41-49) and remained persistent until adulthood [2]. Method Rats were pre-treated with subchronic administration of CP-55940 (n=11, 6 males, 5 females) or vehicle (n=8, 4 males, 4 females) during adolescence (daily i/p injections between PND32-36 or PND42-46, n=10 and 9, respectively). They were then tested in adulthood (PND70-88, n=17 or PND 111-115, n=2) under urethane anesthesia. Hippocampal theta rhythm was elicited by brainstem stimulation at 5 intensity levels one hour before and up to 5 hours after injection. Results We found a lasting significant decrease in theta power after CP-55940 in adult rats which was aggravated further in rats pre-treated with the CB1R agonist. The effect was significantly larger (p=0.0462) in rats pre-treated during early adolescence (PND32-36) compared to the group pre-treated during late adolescence (PND42-46). Discussion & Conclusions We conclude that 1. CP55940 administration decreases HPC theta power in this model; 2. Pre-treatment with CP55940 in adolescence is associated with increased sensitivity to theta power reduction after its re-introduction in adulthood; 3. Early adolescence, a critical period for development of HPC networks generating theta rhythm, is particularly prone to this sensitivity.

Authors

Institutions

Publication Details

Journal
The International Journal of Neuropsychopharmacology
Published
2025-08-01
DOI
https://doi.org/10.1093/ijnp/pyaf052.146
Primary Topic
Neuroscience and Neuropharmacology Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

474. THE EFFECT OF ADOLESCENT PRE-TREATMENT WITH THE SELECTIVE CANNABINOID 1 RECEPTOR AGONIST ON HIPPOCAMPAL THETA SYNCHRONIZATION IN ADULTHOOD

Bernát Kocsis, J Rehn
The International Journal of Neuropsychopharmacology
Neuroscience and Neuropharmacology Research
article

474. THE EFFECT OF ADOLESCENT PRE-TREATMENT WITH THE SELECTIVE CANNABINOID 1 RECEPTOR AGONIST ON HIPPOCAMPAL THETA SYNCHRONIZATION IN ADULTHOOD

Bernát Kocsis, J Rehn
article en

Abstract

Abstract Background Historically, concern around adolescent marijuana use focused on the development of psychosis, however recent findings indicate that cognitive domains may also be at risk. CB1R was shown to interfere with neuronal network oscillations and to impair sensory gating function. Neuronal oscillations are essential in multiple cognitive functions and their impairment was documented in neurological and psychiatric diseases. The Cannabinoid 1-receptor (CB1R), one of the most abundant G-protein coupled receptors in the nervous system, is found in particularly high levels in the hippocampus (HPC). Increased CB1R density and binding observed in patients with schizophrenia and epidemiological studies suggest that regular cannabis use during adolescence is a risk factor for the disease. Aims & Objectives The aim of this study was to investigate how adolescent pre-treatment with the CB1R selective agonist CP-55940 may lead to abnormal theta synchronization in adulthood. Two of our previous findings served as scientific premise of the project: 1. CP-55940 significantly reduced theta and gamma power in HPC in adult freely behaving and theta in anesthetized rats, the latter reversed by CB1R antagonist AM-251 [1] and 2. it was shown in urethane anaesthetized rats that early adolescence is critical for development of HPC networks generating theta rhythm as HPC theta power rapidly decreased through postnatal days PND32-39 with large interindividual variations but stabilized by late adolescence (PND41-49) and remained persistent until adulthood [2]. Method Rats were pre-treated with subchronic administration of CP-55940 (n=11, 6 males, 5 females) or vehicle (n=8, 4 males, 4 females) during adolescence (daily i/p injections between PND32-36 or PND42-46, n=10 and 9, respectively). They were then tested in adulthood (PND70-88, n=17 or PND 111-115, n=2) under urethane anesthesia. Hippocampal theta rhythm was elicited by brainstem stimulation at 5 intensity levels one hour before and up to 5 hours after injection. Results We found a lasting significant decrease in theta power after CP-55940 in adult rats which was aggravated further in rats pre-treated with the CB1R agonist. The effect was significantly larger (p=0.0462) in rats pre-treated during early adolescence (PND32-36) compared to the group pre-treated during late adolescence (PND42-46). Discussion & Conclusions We conclude that 1. CP55940 administration decreases HPC theta power in this model; 2. Pre-treatment with CP55940 in adolescence is associated with increased sensitivity to theta power reduction after its re-introduction in adulthood; 3. Early adolescence, a critical period for development of HPC networks generating theta rhythm, is particularly prone to this sensitivity.

The International Journal of NeuropsychopharmacologyVol. 28(Supplement_2)
Harvard University (US)
Openalex Percentile: Top 77%
Neuroscience and Neuropharmacology Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.